Quantum Computing Inc. (QCi) reported third-quarter revenue of $9.5m, up from $384,000 a year earlier and more than the $9.2m it booked in the whole first half. Most of the growth came from businesses it bought this year, and the company kept only 4.5% of that revenue as gross profit.
Revenue jumps, profit does not follow
The Hoboken, New Jersey company, which makes photonic chips, components and quantum optimisation machines, released the figures on 9 November. Revenue for the first nine months reached $18.7m, against $484,000 a year earlier.
The quarter beat the $7.72m of revenue analysts had expected, according to Earnings Whispers, and the loss of $0.07 a share was a cent better than the consensus.
The cost of that revenue was high. Gross profit was $428,000, a margin of 4.5%. Operating expenses rose to $29.0m from $10.5m a year earlier, including about $1.0m of acquisition costs, leaving an operating loss of $28.6m.
Third quarter 2026
- $9.5m revenue, against $384,000 a year earlier
- 4.5% gross margin
- $15.1m net loss, or $0.07 a share
Quantum Computing Inc.: share price, chart and news

Where the revenue came from
QCi bought three businesses in the first half of 2026: Luminar Semiconductors, which makes photonic components; NuCrypt, a maker of quantum communications products; and NHanced Semiconductors, which provides advanced packaging services. Earnings Whispers, reviewing the release and the call, said nearly all of the revenue growth came from these deals.
The purchases show on the balance sheet. Goodwill rose to $160.3m from $55.6m at the end of 2025, and intangible assets to $62.1m from $6.5m.
On the call, according to the Earnings Whispers summary, management said about 70% of revenue comes from government and aerospace subcontracts. It also pointed to export-control limits on international sales and said a Navy contract at NHanced had been pushed out.

Interest income softens the loss
The net loss was $15.1m, against net income of $2.4m a year earlier. It would have been far larger without $13.0m of interest and other income, earned mainly on the company's large cash and investment balances.
At 30 September QCi held $174.3m in cash and equivalents, $727.3m in short-term investments and $396.2m in long-term investments, about $1.3bn in total including accrued interest. It had 226.9 million shares outstanding.
Backlog fell to $39.1m at the end of September. Earnings Whispers put the figure three months earlier at $42.5m.
| Q3 2026 | Figure |
|---|---|
| Revenue | $9.5m |
| Gross profit | $428,000 |
| Operating expenses | $29.0m |
| Interest and other income | $13.0m |
| Net loss | $15.1m |
| Backlog | $39.1m |
Products and what comes next
On 1 October QCi announced Dirac-3S, a quantum optimisation machine for problems with nearly 10,000 variables, about ten times its current 1,000-variable system. The company demonstrated 9,980 variables with one expansion module. The company said the first customer shipment is expected in November 2026.
During the third quarter it also signed a commercial agreement with INmune Bio, its first pharmaceutical and biotech customer, announced on 14 October. INmune Bio will use Dirac optimisation on clinical and biomedical data for its investigational Alzheimer's treatment. In September it signed a framework agreement with Hamad Bin Khalifa University in Qatar that includes cloud access to Dirac-3.
Chief executive Yuping Huang said the focus is shifting "from what we can build to what we can put to work for customers." QCi gave no numerical guidance. Earnings Whispers reported that a second fabrication plant, Fab2, has been brought forward, with spending of $70m to $80m expected through about mid-2027.
The risks
QCi is still losing money at the operating level, and its 4.5% gross margin shows how little the acquired businesses earn on what they sell. Its reliance on government subcontracts leaves it exposed to budget delays, and export rules limit sales abroad. Building Fab2 will draw on cash, and the interest income that cushions the loss would shrink if the cash pile or interest rates fall.
According to Earnings Whispers, the shares had fallen 30.9% from a $9.16 open after the August report to $6.33, and hit a 52-week low of $5.39 on 5 November.
Sources
- Quantum Computing Inc.: Quantum Computing Inc. Reports Third Quarter 2026 Financial Results
- Finviz: Quantum Computing Inc. Reports Third Quarter 2026 Financial Results (release text)
- Earnings Whispers via Finviz: Quantum Computing Inc tops estimates on acquired revenue, but 4.5% gross margin, rising costs and slipping backlog cloud the beat
- Quantum Computing Inc.: Quantum Computing Inc. Announces Dirac-3S, Advancing Speed, Scale and Solutions for Quantum Optimization
- Quantum Computing Inc.: INmune Bio and Quantum Computing Inc. partner to apply quantum optimization and AI to Alzheimer's drug research








